A spokesperson for HHS told Newsweek that while there had been reports of " unexpected coverage denials at the point of service, " these were being addressed by the government's Centers for Medicare and Medicaid Services.

HHS 的一名发言人告诉《新闻周刊》，虽然有报道称 “服务点意外拒绝承保”，但政府的医疗保险和医疗补助服务中心正在解决这些问题。

Last year, the FDA approved Rydapt, a mast cell disorder and leukemia drug, and the Centers for Medicare and Medicaid Services approved limited reimbursements for its rare-blood-cancer drug, Kymriah, which runs $475,000 for a course of a treatment.

去年，FDA批准了Rydapt这种治疗肥大细胞紊乱和白血病的药物，医疗保险和医疗补助服务中心也批准了对其罕见血癌药物Kymriah发放一定补助的申请，而这种药物一个疗程的费用就高达47.5万美元。